2016
YJ He, ZG Su, LJ Xue, H Xu*, C Zhang*. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. J Control Release.2016. 229: 80-92. (IF: 7.705)
N Zhang, XF Xu, X Zhang, D Qu, LJ Xue*, R Mo, C Zhang*. Nanocomposite hydrogel incorporating gold nanorods and paclitaxel-loaded chitosan micelles for combination photothermal-chemotherapy. Int J Pharm. 2016, 497(1-2): 210-221. (IF: 3.65)
2016 Nanocomposite hydrogel incorporating gold nanorods and.pdf
ZX Ge, MX Hao, M Xu, ZG Su, ZS Kang, LJ Xue**, C Zhang*. Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy. Eur J Med Chem. 2016, 107: 48-62. (IF: 3.447)
2016 Novel nonsecosteroidal VDR ligands with phenyl.pdf
DB Yang, TF Wang, ZG Su*, LJ Xue, R Mo, C Zhang*. Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles. ACS Applied Materials & Interfaces 2016, 8 (34): 22431-22441. (IF: 7.504)
2016 Reversing Cancer Multidrug Resistance in Xenograft Models.pdf
SY Yin, CM Tang, B Wang, Y Zhang, LL Zhou, LJ Xue*, C Zhang*. Design, synthesis and biological evaluation of novel EGFR/HER2 dual inhibitors bearing a oxazolo[4,5-g]quinazolin-2(1H)-one scaffold. European Journal of Medicinal Chemistry 2016, 120: 26-36. (IF: 3.902)
2016 Design, synthesis and biological evaluation of novel EGFR.pdf
TF Wang, XF Liu, MX Hao, JN Qiao, CY Ju, LJ Xue*, C Zhang*. Design, synthesis and evaluation of pyrrolo[2,3-d]pyrimidine-phenylamide hybrids as potent Janus kinase 2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2016, 26(12): 2936-2941. (IF: 2.486)
2016 Design, synthesis and evaluation of pyrrolo.pdf